• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Hyperphosphatemia Drugs Market 2011-2015 Product Image

Global Hyperphosphatemia Drugs Market 2011-2015

  • Published: July 2012
  • 37 pages
  • Infiniti Research Limited

TechNavio's analysts forecast the Global Hyperphosphatemia Drugs market to grow at a CAGR of 12.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of chronic kidney disease. The Global Hyperphosphatemia Drugs market has also been witnessing the trend of an increasing number of strategic alliances among vendors. However, side effects caused by the hyperphosphatemia drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Hyperphosphatemia Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hyperphosphatemia Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Fresenius Medical Care AG & Co. KGaA, Shire plc, and Sanofi S.A.

Other vendors mentioned in the report: Keryx Biopharmaceuticals Inc., Novartis AG, Vifor Pharma AG, Astellas Pharma Inc., Panacor Bioscience READ MORE >

01. Executive Summary
02. Introduction
03. Market Coverage
Overview
Product Offerings
04. Market Landscape
Market Size
Five Forces AnalysiS
05. Geographical Segmentation
06. Key Leading Countries
USA
Japan
Germany
Economic Indicators of Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Sanofi S.A.
SWOT Analysis
15.2 Shire plc.
Business Overview
SWOT Analysis
15.3 Fresenius Medical Care AG & Co. KGaA
Business Overview
SWOT Analysis
16. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Hyperphosphatemia Drugs Market 2011-2015 (US$ million)
Exhibit 2: Global Hyperphosphatemia Drugs Market by Geographical Segmentation 2011
Exhibit 3: Global Hyperphosphatemia Drugs Market by Vendor Segmentation 2011

Fresenius Medical Care AG & Co. KGaA, Shire plc, Sanofi S.A

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
1 - 5 Users The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos